Of note, cancer-associated key nuclear transcribed mutant TP53, KRAS, and EGFR DNA have been detected in the EVs of various cancer patients63–65, which further highlights the potential applicability of the EVs in noninvasive biomarker development. This evidence concerns the gene KRAS and cancer.